Yoga for secondary prevention of coronary heart disease

Joey S W Kwong1, Hoi Lam Caren Lau, Fai Yeung

  • 1Chinese Cochrane Center, Chinese Evidence-Based Medicine Center, West China Hospital, Sichuan University, No. 37, Guo Xue Xiang, Chengdu, Sichuan, China, 610041.

Insights

The effectiveness of yoga for secondary prevention in coronary heart disease (CHD) remains uncertain. More high-quality randomized controlled trials (RCTs) are needed to confirm benefits for patients with CHD.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Integrative Medicine

Background:

  • Coronary heart disease (CHD) is a leading cause of mortality in developed nations.
  • Secondary prevention strategies are crucial for individuals with established CHD.
  • Lifestyle modifications, including yoga, are increasingly recognized for their health benefits.

Purpose of the Study:

  • To evaluate the efficacy of yoga in secondary prevention for individuals with CHD.
  • To assess yoga's impact on mortality, morbidity, and quality of life in CHD patients.

Main Methods:

  • An updated systematic review of randomized controlled trials (RCTs) was conducted.
  • Searches included major databases (CENTRAL, MEDLINE, EMBASE, Web of Science) and clinical trial registries.
  • Studies involving adults with CHD and a minimum six-month follow-up were considered.

Main Results:

  • No eligible RCTs met the inclusion criteria for this updated review.
  • A meta-analysis could not be performed due to the lack of suitable studies.

Conclusions:

  • The role of yoga in the secondary prevention of CHD is currently not established.
  • High-quality, large-scale RCTs are essential to determine yoga's effectiveness in this population.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
861
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.7K
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
5.5K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
592
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
419
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
996